肾脏纤维化是慢性肾脏病的共同病理特征,主要表现为细胞外基质的过度堆积和肾小管萎缩.MicroRNAs(miRNAs)是一类能在转录后水平调节大量基因的微小非编码RNA分子,miRNAs表达失调将导致细胞功能受损和疾病发生.作者综述了肾脏纤维化相关miRNAs的作用机制,着重阐述miR-192、miR-200家族、miR-29家族、miR-21的作用,以及相关miRNAs在肾脏纤维化中的靶向干预作用.

[1] KRUPA A,JENKINS R,LUO D D,et al.Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy[J].J Am Soc Nephrol,2010,21(3): 438-447.
[2] WANG B,HERMAN-EDELSTEIN M,KOH P,et al.E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-β[J].Diabetes,2010,59(7): 1794-1802.
[3] ROBERT H J,JOHN M,ALED O P,et al.Transforming growth factor beta1 represses proximal tubular cell microRNA-192 expression through decreased hepatocyte nuclear factor DNA binding[J].Biochem J,2012,443(2): 407-416.
[4] KATO M,ZHANG J,WANG M,et al.MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors[J].Proc Natl Acad Sci USA,2007,104(9): 3432-37.
[5] KATO M,ARCE L,WANG M,et al.A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells[J].Kidney Int,2011,80(4): 358-368.
[6] KATO M,PUTTA S,WANG M,et al.TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN[J].Nat Cell Biol,2009,11(7): 881-889.
[7] PUTTA S,LANTING L,SUN G,et al.Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy[J].J Am Soc Nephrol,2012,23(3): 458-469.
[8] CHUNG A C K,HUANG X R,MENG X,et al.MiR-192 mediates TGF-β/Smad3-driven renal fibrosis[J].J Am Soc Nephrol,2010,21(8): 1317-1325.
[9] DESHPANDE S D,PUTTA S,WANG M,et al.Transforming growth factor-β induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy[J].Diabetes,2013,62(9): 3151-3162.
[10] ZHOU L,FU P,HUANG X R,et al.Activation of p53 promotes renal injury in acute aristolochic acid nephropathy[J].J Am Soc Nephrol,2010,21(1): 31-41.
[11] WEI Q,BHATT K,HE H Z,et al.Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury[J].J Am Soc Nephrol,2010,21(5): 756-761.
[12] 熊明霞.microRNA在肾间质纤维化中作用的研究.南京: 南京医科大学,2010.
[13] OBA S,KUMANO S,SUZUKI E,et al.MiR-200b precursor can ameliorate renal tubulointerstitial fibrosis[J].PLoS One,2010,5(10): e13614.
[14] TANG O,CHEN X M,SHEN S,et al.MiRNA-200b represses transforming growth factor-betal-induced EMT and fibronectin expression in kidney proximal tubular cells[J].Am J Physiol Renal Physiol,2013,304(10): F1266-73.
[15] WANG B,KOH P,WINBANKS C,et al.MiR-200a prevents renal fibrogenesis through repression of TGF-β2 expression[J].Diabetes,2011,60(1): 280-287.
[16] PARK J T,KATO M,YUAN H,et al.FOG2 down-regulation by TGF-β1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy[J].J Biol Chem,2013,288(31): 22469-22480.
[17] WEI J,ZHANG Y,LUO Y,et al.Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2,Tgf-β1/2,and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice[J].Free Radical Bio Med,2014,67: 91-102.
[18] KRIEGEL A J,LIU Y,FANG Y,et al.The miR-29 family: genomics,cell biology,and relevance to renal and cardiovascular injury[J].Physilo Genomics,2012,44(4): 237-244.
[19] WANG B,KOMERS R,CAREW R,et al.Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis[J].J Am Soc Nephrol,2012,23(2): 252-265.
[20] CHEN H Y,ZHONG X,HUANG X R,et al.MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice[J].Mol Ther,2013,22(4): 842-53.
[21] QIN W,CHUNG A C K,HUANG X R,et al.TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29[J].J Am Soc Nephrol,2011,22(8): 1462-1474.
[22] LONG J,WANG Y,WANG W,et al.MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1,and its in vivo knockdown prevents progression of diabetic nephropathy[J].J Biol Chem,2011,286(13): 11837-11848.
[23] LI N,CUI J,DUAN X,et al.Suppression of type I collagen expression by miR-29b via PI3K,Akt,and Sp1 pathway in human Tenon's fibroblasts[J].Invest Ophth Vis Sci,2012,53(3): 1670-1678.
[24] JIANG L,ZHOU Y,XIONG M,et al.Sp1 mediates microRNA-29c-regulated typeⅠcollagen production in renal tubular epithelial cells[J].Exp Cell Res,2013,319(14): 2254-2265.
[25] FANG Y,YU X,LIU Y,et al.miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-alpha activation[J].Am J Physiol Renal Physiol,2013: 304(10): F1274-82.
[26] LIU G X,LI Y Q,HUANG X R,et al.Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice[J].PLoS One,2013,8(1): e53573.
[27] LÜ L L,CAO Y H,NI H F,et al.MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis[J].Am J Physiol Renal Physiol,2013,305(8): F1220-1227.
[28] ZHANG S,WU S,QU X,et al.Down-regulation of microRNA-29c is associated with renal failure in multiple myeloma[J].Leuk Lymphoma,2014,55(1): 226-228.
[29] ZHONG X,CHUNG A C K,CHEN H Y,et al.Smad3-mediated upregulation of miR-21 promotes renal fibrosis[J].J Am Soc Nephrol,2011,22(9): 1668-1681.
[30] ZHONG X,CHUNG A C K,CHEN H Y,et al.MiR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes[J].Diabetologia,2013,56(3): 663-674.
[31] DEY N,DAS F,MARIAPPAN M M,et al.MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1,resulting in renal cell pathology in diabetes[J].J Biol Chem,2011,286(29): 25586-25603.
[32] ZHOU Y,XIONG M,FANG L,et al.MiR-21-containing microvesicles from injured tubular epithelial cells promote tubular phenotype transition by targeting PTEN protein[J].Am J Pathol,2013,183(4): 1183-1196.
[33] CHAU B N,XIN C,HARTNER J,et al.MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways[J].Sci Transl Med,2012,4(121): 121ra18.
[34] WANG J,GAO Y,MA M,et al.Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice[J].Cell Biochem Biophys,2013,67(2): 537-546.
[35] GLOWACKI F,SAVARY G,GNEMMI V,et al.Increased circulating miR-21 levels are associated with kidney fibrosis[J].PLoS One,2013,8(2): e58014.
[36] ELMEN J,LINDOW M,SCHUTZ S,et al.LNA-mediated microRNA silencing in non-human primates[J].Nature,2008,452(7189): 896-899.
[37] PUTTA S,LANTING L,SUN G,et al.Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy[J].J Am Soc Nephrol,2012,23(3): 458-469.
[38] van ROOIJ E,SUTHERLAND L B,THATCHER J E,et al.Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis[J].P Natl Acad Sci USA,2008,105(35): 13027-13032.
[39] LÜ L L,CAO Y H,LIU D,et al.Isolation and quantification of MicroRNAs from urinary exosomes/microvesicles for biomarker discovery[J].Int J Biol Sci,2013,9(10): 1021-1031.